Revvity | PKI - Operating Expenses


Revvity reported $603.55M in Operating Expenses for its fiscal quarter ending in June of 2026.





Operating Expenses Change Date
Agilent USD 1.44B 9M Mar/2026
Align Technology USD 864.87M 2.84M Jun/2026
Bio Techne USD 235.92M 5.5M Mar/2026
Bio-Rad Laboratories USD 7.17B 322.6M Jun/2026
Bruker USD 768.9M 44.3M Jun/2026
Celltrion KRW 119.22B 21.46B Mar/2026
Charles River Laboratories USD 2.84B 1.96B Jun/2026
Cspc Pharmaceutical CNY 5.91B 512.77M Dec/2025
Danaher USD 52.58B 368M Jun/2026
Dentsply International USD 1.35B 33M Jun/2026
Deva Holding AS TRY 1.35B 178.26M Sep/2023
Dianthus Therapeutics USD 47M 22.83M Mar/2026
Divis Laboratories Ltd INR 19.51B 660M Jun/2026
Edwards Lifesciences USD 1.22B 87.6M Jun/2026
Illumina USD 899M 47M Jun/2026
Intuitive Surgical USD 1.91B 3.6M Jun/2026
IQVIA Holdings USD 1.77B 4.45B Jun/2026
Kangmei Pharma CNY 1.09B 304.02M Mar/2026
Knight Therapeutics CAD 126.9M 8.29M Dec/2025
Laboratorios Farma EUR 313.62M 17.98M Dec/2023
Laboratory Of America USD 3.27B 146.9M Jun/2026
Malin Corporation EUR 1.1M 400K Dec/2024
Medical Developments International AUD 21.61M 11.59M Dec/2025
Mesa Laboratories USD 33.98M 2.03M Dec/2024
Mettler Toledo International USD 739.77M 26.57M Jun/2026
Myriad Genetics USD 212.8M 16.2M Dec/2025
Neuren Pharmaceuticals AUD 25.23M 16.54M Dec/2025
OraSure Technologies USD 40.35M 2.45M Dec/2025
Organigram Holdings CAD 69.59M 14.08M Mar/2026
Ovoca Bio EUR 173K 990K Dec/2025
Pacific Biosciences Of California USD 97.83M 41.29M Dec/2025
Pharma Mar EUR 51.01M 8.73M Jun/2026
Qiagen NV USD 393.64M 17.95M Jun/2026
Quest Diagnostics USD 2.58B 88M Jun/2026
Quidel USD 646.2M 1.21B Jun/2026
Repligen USD 183M 8.72M Jun/2026
Revvity USD 603.55M 24.8M Jun/2026
Sartorius EUR 747.8M 9.4M Jun/2026
Sino Biopharmaceutical CNY 12.39B 1.26B Jun/2025
Thermo Fisher Scientific USD 9.81B 716M Jun/2026
Tilray USD 237.52M 17.34M Sep/2025
Waters USD 527M 592M Jun/2026
Zealand Pharma A/S 573M 202.97M Mar/2026
Zz Pientze Pharmaceu CNY 1.88B 326.34M Mar/2026